Open AccessComparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
Author(s) -
Nathan E. Richards,
Behnam Keshavarz,
Lisa J. Workman,
Michael R. Nelson,
Thomas A.E. PlattsMills,
Jeffrey M. Wilson
Publication year - 2021
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2021.24331
Subject(s) - immunogenicity , medicine , antibody , covid-19 , antibody response , neutralizing antibody , messenger rna , cohort , immunology , virology , biology , gene , biochemistry , disease , outbreak , infectious disease (medical specialty)
This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom